Phase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma: Hoosier Cancer Research Network LUN15-299

Learn more:

• https://clinicaltrials.gov/study/NCT03502746
• See news release

Manuscripts/Articles: 

• Arkadiusz Dudek, Min Xi, Katherine Scilla, Hirva Mamdani, Benjamin Creelan, Andreas Saltos, Tawee Tanvetyanon, Alberto Chiappori. Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: Hoosier Cancer Research Network LUN15-299. DOI: 10.1016/j.jtocrr.2023.100584 JTO Clinical Research Reports. 2023 October 11. See Abstract.